Total Funding
62
51
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
144962
Entopsis is a developer of novel biomedical products that allows for direct PCR from clinical samples.
George Huang: CFO
Ian Cheong: Co-Founder
About the Company
Entopsis is a privately held company developing novel biomedical products for research and clinical use, predominantly in the areas of oncology, autoimmune disorders, metabolic disorders, and developing world malignancies. The company has established various strategic industry and academic research collaborations geared towards advancing company
goals.
It was incorporated in 2011 and is headquartered in Hialeah, Florida.
